Form 4 for ROG ROGERS CORP
Accepted 2023-03-10 00:00:00 ET · period of report 2023-03-09 · accession 0001664272-23-000209 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-10 | 2023-03-09 | ROG | Roby Anne K | Dir | A - Grant | $0.00 | +200 | 200 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Capital (Common) Stock | 2023-03-09 | A | A | 200 | $0.00 | 200 | D | — | — | (F1) Dr. Roby was appointed to the Board of Directors of Issuer on February 26, 2023. This figure represents the number of shares of the Issuer's Capital (Common) Stock receivable pursuant to the deferred stock units granted to Dr. Roby on March 9, 2023. The award is consistent with Issuer's compensatory arrangements for non-management directors, as described in the Form 10-K filed on February 22, 2022, and has been prorated based on the date of Dr. Roby's appointment to the Board. |